[HTML][HTML] Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy

TI Adelusi, L Du, M Hao, X Zhou, Q Xuan, C Apu… - Biomedicine & …, 2020 - Elsevier
Hyperglycemia/oxidative stress has been implicated in the initiation and progression of
diabetic complications while the components of Keap1/Nrf2/ARE signaling are being …

Oxidative stress and NRF2/KEAP1/ARE pathway in diabetic kidney disease (DKD): new perspectives

DM Tanase, EM Gosav, MI Anton, M Floria… - Biomolecules, 2022 - mdpi.com
Diabetes mellitus (DM) is one of the most debilitating chronic diseases worldwide, with
increased prevalence and incidence. In addition to its macrovascular damage, through its …

The Nrf2/Keap1/ARE pathway and oxidative stress as a therapeutic target in type II diabetes mellitus

JA David, WJ Rifkin, PS Rabbani… - Journal of diabetes …, 2017 - Wiley Online Library
Despite improvements in awareness and treatment of type II diabetes mellitus (TIIDM), this
disease remains a major source of morbidity and mortality worldwide, and prevalence …

The emerging role of redox-sensitive Nrf2–Keap1 pathway in diabetes

E Bhakkiyalakshmi, D Sireesh, P Rajaguru… - Pharmacological …, 2015 - Elsevier
The pathogenic processes involving in the development of diabetes range from autoimmune
destruction of pancreatic β-cells with consequent insulin deficiency to abnormalities that …

Targeting the KEAP1-NRF2 system to prevent kidney disease progression

M Nezu, N Suzuki, M Yamamoto - American journal of nephrology, 2017 - karger.com
Background: Nuclear factor erythroid 2-related factor 2 (NRF2) is a critical transcription factor
for the antioxidative stress response and it activates a variety of cytoprotective genes related …

[HTML][HTML] Nrf2 activators as attractive therapeutics for diabetic nephropathy

JB De Haan - Diabetes, 2011 - ncbi.nlm.nih.gov
Diabetes is the major cause of chronic kidney disease worldwide (1) with treatment options
focused primarily on glucose control, blood pressure, lipid lowering, and the blockade of the …

[HTML][HTML] Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: therapeutic targeting, challenges and future prospective

M Hashemi, MA Zandieh, S Ziaolhagh… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Western lifestyle contributes to an overt increase in the prevalence of metabolic anomalies
including diabetes mellitus (DM) and obesity. Prevalence of DM is rapidly growing …

Role of Nrf2 dysfunction in the pathogenesis of diabetic nephropathy: Therapeutic prospect of epigallocatechin-3-gallate

T Mohan, KKS Narasimhan, DB Ravi… - Free Radical Biology …, 2020 - Elsevier
Diabetic nephropathy (DN), a progressive kidney disease afflicts more than 20 and up to
40% of the diabetic population and it is characterized by persistent microalbuminuria …

Recent advances in understanding Nrf2 agonism and its potential clinical application to metabolic and inflammatory diseases

MJ Kim, JH Jeon - International Journal of Molecular Sciences, 2022 - mdpi.com
Oxidative stress is a major component of cell damage and cell fat, and as such, it occupies a
central position in the pathogenesis of metabolic disease. Nuclear factor-erythroid-derived 2 …

The pivotal role of nuclear factor erythroid 2-related factor 2 in diabetes-induced endothelial dysfunction

A Karan, E Bhakkiyalakshmi, R Jayasuriya… - Pharmacological …, 2020 - Elsevier
Endothelial dysfunction (ED) is a key event in the onset and progression of vascular
complications associated with diabetes. Regulation of endothelial function and the …